Surgery can suppress in vivo levels of NK cell cytotoxicity (NKCC) through various mechanisms, including catecholamine-, glucocorticoid (CORT)-, and prostaglandin (PG)-mediated responses. However, PGs are synthesized locally following tissue damage, driving proinflammatory and CORT responses, while their systemic levels are often unaffected. Thus, we herein studied the role of adrenal factors in mediating in vivo effects of PGs on NKCC, using adrenalectomized and sham-operated F344 rats subjected to surgery or PGE 2 administration. In vivo and ex vivo approaches were employed, based on intravenous administration of the NK-sensitive MADB106 tumor line, and based on ex vivo assessment of YAC-1 and MADB106 target-line lysis. Additionally, in vitro studies assessed the kinetics of the impact of epinephrine, CORT, and PGE 2 on NKCC. The results indicated that suppression of NKCC by epinephrine and PGE 2 are short lasting, and cannot be evident when these compounds are removed from the in vitro assay milieu, or in the context of ex vivo assessment of NKCC. In contrast, the effects of CORT are long-lasting and are reflected in both conditions even after its removal. Marginating-pulmonary NKCC was less susceptible to suppression than circulating NKCC, when tested against the xenogeneic YAC-1 target line, but not against the syngeneic MADB106 line, which seems to involve different cytotoxicity mechanisms. Overall, these findings indicate that elevated systemic PG levels can directly suppress NKCC in vivo, but following laparotomy adrenal hormones mediate most of the effects of endogenously-released PGs. Additionally, the ex vivo approach seems limited in reflecting the short-lasting NK-suppressive effects of catecholamines and PGs.
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Introduction
Natural Killer (NK) cells play a significant role in immune protection against virally infected cells and malignant cells, and in controlling cancer metastasis (Biron and Brossay, 2001; Shakhar and Ben-Eliyahu, 1998) . Stress and surgical excision of a primary tumor are associated with immune suppression, specifically reduction in NK cell cytotoxicity (NKCC), and surgery is suggested to promote metastatic progression through immune suppression (Neeman and Ben-Eliyahu, 2012; Neeman et al., 2012; Neuhaus et al., 2000) and through direct effects of stress factors on the remaining malignant tissue (Guillermo et al., 2012) .
Potential mechanisms through which stress and surgery can suppress NK activity have been studied in vitro and in vivo, and substantial evidence support the involvement of various factors, among them are catecholamines (Ben-Eliyahu et al., 2000; Shakhar and Ben-Eliyahu, 1998) , glucocorticoids (CORT) (Deguchi et al., 1998; Shakhar and Blumenfeld, 2003) and prostaglandins (PGs) (Baxevanis et al., 1993; Skibinski et al., 1992; Yakar et al., 2003) , all of which are elevated during the perioperative period (Neeman and Ben-Eliyahu, 2012) .
Specifically, psychological and physiological stressors activate the sympathetic nervous system (SNS) and the HPA axis, leading to the release of catecholamines and CORT, respectively. Studies have shown that b-adrenergic agonists can suppress NK cell activity in vitro (Takamoto et al., 1991; Whalen and Bankhurst, 1990) and in vivo (Shakhar and Ben-Eliyahu, 1998), and consequently can promote cancer metastasis in animal models. Furthermore, b-adrenergic blockade was shown to prevent suppression of NK activity and promotion of cancer metastasis by stress and surgery (Ben-Eliyahu et al., 2000) . CORT was shown to cause a marked suppression of NK cytotoxicity in vitro, in presumably physiological levels (Ben-Eliyahu, 1998; Gatti et al., 1986) , but in vivo studies
